PhRMA guidelines for DTC on deck
Executive Summary
Pharmaceutical Research and Manufacturers of America is expected to release its revised guidelines for direct-to-consumer ads in early 2009, Hugh O'Neill, Sanofi-Aventis' head of market access and business development, reported at a conference on DTC Oct. 29. He indicated the code will include some type of moratorium on ads (1"The Pink Sheet," July 21, 2008, p. 27). Good news for PhRMA: Billy Tauzin, the trade group's president, "expects to be back on the job in the very near future," according to Senior VP Ken Johnson. Tauzin is on medical leave, but the association is "in daily contact with Billy as we begin to make plans for next year," Johnson says. "The great news is that he remains cancer-free and expects to remain at the helm of PhRMA for many years to come." Tauzin often uses a personal account of his battle with cancer, and the role of pharmaceuticals in his recovery, as part of his advocacy for the industry (2"The Pink Sheet," March 28, 2005, p. 31)
You may also be interested in...
“The New PhRMA:” Education, Communication Are Cornerstones, Tauzin Says
The Pharmaceutical Research & Manufacturers of America will become a resource to support communications efforts by member companies as part of an expanded mission, PhRMA CEO Billy Tauzin told the trade association March 18 in Washington, D.C
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.